Citius Pharmaceuticals Inc <CTXR.OQ> expected to post a loss of 59 cents a share - Earnings Preview
Citius Pharmaceuticals Inc CTXR.OQ CTXR.O is expected to show a rise in quarterly revenue when it reports results on August 11 (estimated) for the period ending June 30 2025
The Cranford New Jersey-based company is expected to report revenue of $4.319 million, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Citius Pharmaceuticals Inc is for a loss of 59 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Citius Pharmaceuticals Inc is $5.00, about 74.2% above its last closing price of $1.29
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -1.03 | -0.38 | -1.27 | Missed | -231.3 |
Dec. 31 2025 | -1.38 | -0.58 | -1.30 | Missed | -125.4 |
Sep. 30 2024 | -1.73 | -1.50 | -1.59 | Missed | -6.1 |
Jun. 30 2024 | -1.24 | -1.25 | -1.50 | Missed | -20 |
Mar. 31 2024 | -1.50 | -1.50 | -1.25 | Beat | 16.7 |
Dec. 31 2023 | 3.25 | 3.25 | -1.50 | Missed | -146.2 |
Sep. 30 2023 | -0.50 | -2.00 | Missed | -300 | |
Jun. 30 2023 | -1.42 | -1.37 | -1.50 | Missed | -9.1 |
This summary was machine generated August 8 at 12:38 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
China July Inflation Commentary: CPI Exceeds Expectations
TradingKey - On 9 August 2025, China's National Bureau of Statistics released inflation data for July. The Consumer Price Index (CPI) rose by 0.4% month-on-month, reversing the previous month's 0.1% decline, while remaining unchanged year-on-year. Core CPI increased by 0.8% year-on-year.
U.S. CPI Preview: Bullish Outlook for U.S. Stocks Continues
TradingKey - On 12 August 2025, the U.S. will release its July CPI data. Market consensus forecasts a year-over-year headline CPI increase of 2.8% and a core CPI rise of 3%, both up 0.1 percentage points from June. We align with these widely held market expectations. Breaking it down by category...
U.S. GDP, PCE, and Fed Rate Decision Commentary: Will U.S. Stocks Continue to Rise?
TradingKey - On 30–31 July 2025, the United States released its latest GDP and PCE data, while the Federal Reserve announced its interest rate decision during the same period.
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.
